HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623719
Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 6:44:23 PM
Last modification on : Tuesday, April 12, 2022 - 3:19:13 AM

Identifiers

Citation

Alexandre de Nonneville, Anthony Gonçalves, Christophe Zemmour, Jean Classe, Monique Cohen, et al.. Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study. Breast Cancer Research and Treatment, Springer Verlag, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩. ⟨hal-03623719⟩

Share

Metrics

Record views

2